Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The CAMPATH-1 antigen (CDw52).

× No keyword cloud information.

57 in total

Review 1. Promising approaches in acute leukemia.

Authors: J Cortes; H M Kantarjian
Journal: Invest New Drugs Date: 2000-02 Impact factor: 3.850

Review 2. Failure of hypomethylating agent-based therapy in myelodysplastic syndromes.

Authors: Tapan M Kadia; Elias Jabbour; Hagop Kantarjian
Journal: Semin Oncol Date: 2011-10 Impact factor: 4.929

3. Recognition of CD52 allelic gene products by CAMPATH-1H antibodies.

Authors: C Hale; M Bartholomew; V Taylor; J Stables; P Topley; J Tite
Journal: Immunology Date: 1996-06 Impact factor: 7.397

Review 4. Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.

Authors: Xu Zhang; Raymond Hupperts; Marc De Baets
Journal: Immunol Res Date: 2003 Impact factor: 2.829

5. Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys.

Authors: M R L Marco; E M Dons; D J van der Windt; J K Bhama; L T Lu; A F Zahorchak; F G Lakkis; D K C Cooper; M B Ezzelarab; A W Thomson
Journal: Transpl Immunol Date: 2013-10-09 Impact factor: 1.708

6. Infectious complications of immune modulatory agents.

Authors: Ricardo M La Hoz; John W Baddley
Journal: Curr Infect Dis Rep Date: 2013-12 Impact factor: 3.725

7. Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy.

Authors: Liuyan Jiang; Constance M Yuan; Julia Hubacheck; John E Janik; Wyndham Wilson; John C Morris; Gregory A Jasper; Maryalice Stetler-Stevenson
Journal: Br J Haematol Date: 2009-02-19 Impact factor: 6.998

Review 8. Monoclonal antibodies in the treatment of chronic lymphocytic leukemia.

Authors: Nina Shih Liu; Susan O'Brien
Journal: Med Oncol Date: 2004 Impact factor: 3.064

9. Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells.

Authors: W Rowan; J Tite; P Topley; S J Brett
Journal: Immunology Date: 1998-11 Impact factor: 7.397

10. Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis.

Authors: M Q Xia; G Hale; M R Lifely; M A Ferguson; D Campbell; L Packman; H Waldmann
Journal: Biochem J Date: 1993-08-01 Impact factor: 3.857